查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726208

配方开发外包市场规模、份额、趋势分析报告：按服务、配方、治疗领域、最终用途、地区、细分市场预测，2025-2030 年

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report By Service (Preformulation, Formulation Development), By Formulation, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医药开发外包市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球配方开发外包市场规模预计到2030年将达到606.6亿美元，2025年至2030年期间的复合年增长率为8.62%。

慢性病和感染疾病的沉重负担、对提高难溶性药物生物生物有效性关注以及与药物开发相关的併发症，都导致了全球对製剂开发服务的需求。此外，COVID-19 疫情影响了对实验室检测的需求，以寻找针对传染性病毒的有效治疗方法。因此，人们在研发（R&D）方面投入了大量资金来开发治疗方法，预计这将推动市场的发展。

根据《2022年医药研发年度回顾》，2022年在研的领先药物是生物製药和抗癌药物，预计疫情过后这些药物的製剂开发需求将会有所提升。在全球范围内，製药公司对研发活动的贡献巨大。例如，默克公司2020年的研发费用为25.168亿美元，2019年为24.948亿美元。同样，Biogen公司2020年的研发费用为39.909亿美元。该公司的研发费用与2019年相比成长了75%。研发支出的大幅增加可能会对市场产生正面影响。

由于配方开发相关的併发症，大量药物从未进入后期临床试验。此外，对药物开发的严格规定进一步推动了外包配方开发的需求。预计这些因素将导致需求增加。由于世界各地活性化， COVID-19 发生率已大幅下降。因此，CRO 和 CDMO 正重新将精力集中在肿瘤学和其他疾病的药物开发上。例如，2022 年 4 月，Labcorp 与 Xcell Biosciences 合作，帮助该公司开发治疗癌症、帕金森氏症和其他罕见疾病的细胞和基因疗法。 CDMO 的这些努力预计将推动用于治疗癌症和其他罕见疾病的药物外包配方开发的需求。

医药开发外包市场报告重点

  • 按服务划分，预计预测期内预配方部分将以最快的复合年增长率成长。
  • 预计配方部分在预测期内将出现显着的复合年增长率。
  • 根据治疗领域，肿瘤学在 2024 年占据最大的市场收益占有率。
  • 由于大量 CRO 提供具有成本效益的配方开发服务，预计亚太地区将在 2024 年占据最大的收益占有率。

目录

第一章调查方法与范围

第二章执行摘要

第三章配方开发外包市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验量分析（2024年）
    • 各地区临床试验总数
    • 临床试验总数（依阶段）
    • 临床试验总数（依研究设计）
    • 按主要治疗领域分類的临床试验总数
  • 定价模式分析
  • 科技
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章：医药开发外包市场：按服务的估计与趋势分析

  • 医药开发外包市场（按服务）：细分仪表板
  • 医药开发外包市场（按服务）：波动分析
  • 按服务分类，2018-2030 年
  • 混合前
  • 配方开发

第五章 配方开发外包市场：依配方进行的估算与趋势分析

  • 配方开发外包市场（按配方）：细分仪表板
  • 配方开发外包市场（按配方）：趋势分析
  • 按配方，2018-2030年
  • 口服
  • 注射
  • 局部的
  • 其他的

第六章：医药开发外包市场：依治疗领域的估计与趋势分析

  • 配方开发外包市场（按治疗领域）：细分仪表板
  • 配方开发外包市场（按治疗领域）：差异分析
  • 依治疗领域，2018-2030年
  • 肿瘤学
  • 感染疾病
  • 神经病学
  • 血液学
  • 呼吸系统
  • 心血管系统
  • 皮肤科
  • 其他的

第七章：医药开发外包市场：依最终用途的估计与趋势分析

  • 配方开发外包市场（按最终用途）：细分仪表板
  • 配方开发外包市场（依最终用途）：差异分析
  • 依最终用途，2018-2030 年
  • 製药和生物製药公司
  • 政府和学术机构
  • 其他的

第八章：医药开发外包市场：按地区估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞士
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 印尼
    • 马来西亚
    • 新加坡
    • 泰国
    • 台湾
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 埃及
    • 以色列
    • 科威特

第九章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • SGS SA
    • Intertek Group plc
    • Recipharm
    • Lonza
    • Charles River Laboratories International, Inc.
    • Eurofins Scientific SE
    • Element
    • Labcorp
    • Thermo Fisher Scientific, Inc.
    • Catalent Inc.

第十章 主要建议

Product Code: GVR-4-68039-948-0

Formulation Development Outsourcing Market Growth & Trends:

The global formulation development outsourcing market size is estimated to reach USD 60.66 billion by 2030, registering a CAGR of 8.62% from 2025 to 2030, according to a new report by Grand View Research, Inc. The high burden of chronic and infectious diseases, the growing focus on improving the bioavailability of poorly soluble drugs, and the complications associated with drug development are contributing to the demand for formulation development services globally. Furthermore, the COVID-19 outbreak has influenced the need for clinical trials to find an effective treatment against the contagious virus. This has resulted in significant investments in research and development (R&D) to develop therapeutics, which are expected to drive the market.

According to Pharma R&D Annual Review 2022, biopharmaceutical and anticancer drugs are the major drugs in the development stage in the year 2022, this is expected to improve the demand for formulation development of these drugs post-pandemic. Globally, the pharmaceutical companies are making significant contributions to R&D activities. For instance, Merck's R&D cost was USD 2,516.8 million in 2020 as compared to USD 2,494.8 million in 2019. Similarly, Biogen's R&D expenses accounted for USD 3,990.9 million in 2020. The company's R&D expenditure increased by 75% as compared to 2019. The significant increase in R&D expenditure is likely to have a positive impact on the market.

A significant number of drugs fail to reach late-stage clinical trials owing to complications associated with formulation development. Moreover, strict regulations regarding the development of drugs are further contributing to the demand for outsourcing formulation development. Such factors are expected to improve the demand. The COVID-19 incidence has been significantly reduced owing to the growing vaccination drive globally. As a result, the CRO and CDMO are once again concentrating on the development of drugs for oncology and other disorders. For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson's disease, and other rare diseases. Such initiatives by the CDMOs are likely to promote the demand for the formulation development outsourcing of drugs used in the treatment of cancer and other rare diseases.

Formulation Development Outsourcing Market Report Highlights:

  • Based on services, the preformulation segment is expected to grow at the fastest CAGR during the forecast period.
  • Based on formulation, the drug product segment is expected to grow at a significant CAGR during the forecast period.
  • Based on therapeutic area, the oncology segment accounted for the largest market revenue share in 2024.
  • Asia Pacific held the largest revenue share in 2024, due to the presence of a significant number of CROs providing cost effective formulation development services.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Formulation
    • 1.2.3. Therapeutic Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Formulation Development Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number of Clinical Trials By Region
    • 3.3.2. Total Number of Clinical Trials, By Phase
    • 3.3.3. Total Number of Clinical Trials, By Study Design
    • 3.3.4. Total Number of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Formulation Development Outsourcing Market: Service Estimates & Trend Analysis

  • 4.1. Formulation Development Outsourcing Market, By Service: Segment Dashboard
  • 4.2. Formulation Development Outsourcing Market, By Service: Movement Analysis
  • 4.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.4. Preformulation
    • 4.4.1. Preformulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Formulation Development
    • 4.5.1. Formulation Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Formulation Development Outsourcing Market: Formulation Estimates & Trend Analysis

  • 5.1. Formulation Development Outsourcing Market, By Formulation: Segment Dashboard
  • 5.2. Formulation Development Outsourcing Market, By Formulation: Movement Analysis
  • 5.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Formulation, 2018 - 2030
  • 5.4. Oral
    • 5.4.1. Oral Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Injectable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Topical
    • 5.6.1. Topical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Formulation Development Outsourcing Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Formulation Development Outsourcing Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Formulation Development Outsourcing Market, By Therapeutic Area: Movement Analysis
  • 6.3. Formulation Development Outsourcing Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Infectious Disease
    • 6.5.1. Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Neurology
    • 6.6.1. Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Hematology
    • 6.7.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Respiratory
    • 6.8.1. Respiratory Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Dermatology
    • 6.10.1. Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Formulation Development Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. Formulation Development Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. Formulation Development Outsourcing Market, By End Use: Movement Analysis
  • 7.3. Formulation Development Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 7.4. Pharmaceutical and Biopharmaceutical Companies
    • 7.4.1. Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Government and Academic Institutes
    • 7.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Formulation Development Outsourcing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Netherlands
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Switzerland
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.10. Denmark
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Framework
      • 8.5.10.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.11. Norway
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Framework
      • 8.5.11.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Japan
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Indonesia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Indonesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.8. Malaysia
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.9. Singapore
      • 8.6.9.1. Key Country Dynamics
      • 8.6.9.2. Competitive Scenario
      • 8.6.9.3. Regulatory Framework
      • 8.6.9.4. Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.10. Thailand
      • 8.6.10.1. Key Country Dynamics
      • 8.6.10.2. Competitive Scenario
      • 8.6.10.3. Regulatory Framework
      • 8.6.10.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.11. Taiwan
      • 8.6.11.1. Key Country Dynamics
      • 8.6.11.2. Competitive Scenario
      • 8.6.11.3. Regulatory Framework
      • 8.6.11.4. Taiwan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Colombia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Chile
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Egypt
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Egypt Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.6. Israel
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory Framework
      • 8.8.6.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.7. Kuwait
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Competitive Scenario
      • 8.8.7.3. Regulatory Framework
      • 8.8.7.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. SGS S.A.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Intertek Group plc
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Recipharm
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Lonza
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Charles River Laboratories International, Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Eurofins Scientific SE
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Element
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Labcorp
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Thermo Fisher Scientific, Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Catalent Inc.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

Chapter 10. Key Recommendations

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 5 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 Global Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 11 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 North America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 14 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 15 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 16 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 18 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 19 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 20 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 22 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 23 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 27 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 28 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 31 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 32 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 33 UK Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 35 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 36 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 37 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 39 France Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 40 France Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 41 France Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 43 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 44 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 45 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 47 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 48 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 52 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 53 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 56 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 57 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 59 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 60 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 61 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 63 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 64 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 67 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 68 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 69 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 75 China Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 76 China Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 77 China Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 78 China Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 79 India Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 80 India Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 81 India Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 82 India Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 83 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 84 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 85 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 88 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 89 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 90 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 91 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 92 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 93 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 94 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 95 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 96 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 97 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 98 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 99 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 100 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 101 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 102 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 103 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 104 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 105 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 108 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 109 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 110 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 111 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 112 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 113 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 114 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 115 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 116 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 117 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 118 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 119 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 121 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 122 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 123 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 124 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 126 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 129 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 130 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 131 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 132 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 133 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 134 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 135 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 136 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 137 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 138 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 139 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 140 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 141 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 142 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 143 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 144 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 145 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 146 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 147 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 149 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 150 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 151 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 152 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 153 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 154 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 155 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 156 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 157 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 158 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 159 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 160 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 161 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 162 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018 - 2030 (USD Million)
  • Table 163 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 164 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Formulation Development Outsourcing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Formulation Development Outsourcing Market: Service outlook and key takeaways
  • Fig. 20 Formulation Development Outsourcing Market: Service movement analysis
  • Fig. 21 Preformulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Formulation Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Formulation Development Outsourcing Market: Formulation outlook and key takeaways
  • Fig. 24 Formulation Development Outsourcing Market: Formulation movement analysis
  • Fig. 25 Oral Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Injectable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Topical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Formulation Development Outsourcing Market: Therapeutic Area outlook and key takeaways
  • Fig. 30 Formulation Development Outsourcing Market: Therapeutic Area Movement Analysis
  • Fig. 31 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Respiratory Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Formulation Development Outsourcing Market: End Use outlook and key takeaways
  • Fig. 40 Formulation Development Outsourcing Market: End Use movement analysis
  • Fig. 41 Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Government and Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 North America Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 France Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Italy Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Norway Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Japan Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Australia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Chile Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 MEA Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 UAE Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Israel Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Key company categorization
  • Fig. 117 Service heat map analysis
  • Fig. 118 Strategic framework